PRIME AGING BRAIN DIAGNOSTICS
Zzf36-1016	Alzheimers Screening and Prevention (ASAP) Act.
	Quote:	Last year, the Food and Drug Administration (FDA) cleared two new blood-based diagnostic tests for Alzheimers. This is massive news for patients and their families looking for answers about their brain health in increasingly desperate fashion. These tests are a significant and necessary improvement over traditional alternatives such as positron emission tomography scans or CSF testing, a particularly cringeworthy procedure in which a specialist must perform a spinal tap. These new blood-based tests are both less expensive and far less invasive. Research is also underway to evaluate whether blood tests such as these could help detect Alzheimers well before patients begin to show symptoms.... Thankfully, a solution is on the table to help clear a path for patients to benefit from these advances: the Alzheimers Screening and Prevention (ASAP) Act. The ASAP Act would allow Medicare coverage of FDA-cleared blood tests for routine Alzheimers screening. Experts agree that expanding access to early screening must be the starting point for addressing this crisis.
	Article:	https://pjmedia.com/christian-josi/2026/09/09/pass-asap-asap-n4957037
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho

Javilk's Research Links Newsletter for Week 36
Updated 09/15/2026-02:09:31 AM
What interests you? What have you found? Tell me!
Drop me a note at Javilk.com to subscribe or submit something.

Zzf36-1016

Alzheimers Screening and Prevention (ASAP) Act.